Abstract
Liquid biopsy is a promising clinical tool that can provide critical information for prognostication and which may inform treatment decisions in men with metastatic castration-resistant prostate cancer. Here we discuss the Foundation Medicine plasma cell-free circulating tumor DNA assay, its pros and cons, and potential clinical utility.
Cite
CITATION STYLE
APA
Hawkey, N. M., & Armstrong, A. J. (2021). Liquid biopsy: It’s the bloody truth! Clinical Cancer Research, 27(11), 2961–2963. https://doi.org/10.1158/1078-0432.CCR-21-0531
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free